NYSE:AZN

Seroquel Stepping Stone: How Luye Will Use Seroquel to Expand in Emerging Markets

SHANGHAI, June 7, 2018 /PRNewswire/ -- The $538 million acquisition by Luye Pharma Group Ltd. (HKSE:2186) of Seroquel quetiapine fumarate from AstraZeneca plc (LSE:AZN; NYSE:AZN) will lay the commercial groundwork in new emerging markets for the Chinese pharma's internal CNS pipeline. On May 7, ...

2018-06-07 07:45 2986

Week's Top Stories